Article
FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth
30 Jul 2023
Abstract excerpt
Cyclin-dependent kinase 4 (CDK4) and retinoblastoma protein (RB) are both important cell-cycle regulators that function in different scenarios. Here, we report that FERM domain-containing 8 (FRMD8) inhibits CDK4 activation and stabilizes RB, thereby causing cell-cycle arrest and inhibiting colorectal cancer (CRC) cell growth. FRMD8 interacts separately with CDK7 and CDK4, and it disrupts the interaction of CDK7...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
